+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orifarm Group AS - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 37 Pages
  • October 2024
  • GlobalData
  • ID: 2424750
Orifarm Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Orifarm Group A/S (Orifarm) is a healthcare company. It focuses on the manufacturing, commercialization, and trading of pharmaceutical products. The company imports, repackages, and sells medicine; provides off-patent, small molecule medicine; and supplies consumer healthcare products. Orifarm's product portfolio includes pharmaceuticals for primary and secondary care, over-the-counter (OTC) products, and consumer healthcare products. The company supplies its products to wholesalers, pharmacies, hospitals, and patients. It has an operational presence in Europe and the US. Orifarm is headquartered in Odense, Denmark.

Orifarm Group AS Key Recent Developments

  • Aug 28, 2024: Orifarm Group Appoints New CFO
  • May 05, 2024: Orifarm Data Community talks AI and machine-learning
  • Apr 23, 2024: Orifarm Prepares for Further Growth
  • Apr 09, 2024: Orifarm launches its own Artificial Intelligence tools

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Orifarm Group A/S - Key Facts
  • Orifarm Group A/S - Key Employees
  • Orifarm Group A/S - Key Employee Biographies
  • Orifarm Group A/S - Major Products and Services
  • Orifarm Group A/S - History
  • Orifarm Group A/S - Company Statement
  • Orifarm Group A/S - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Orifarm Group A/S - Business Description
  • Product Category: Consumer Healthcare & Specialty Rx
  • Performance
  • Product Category: Other Revenue
  • Performance
  • Product Category: Pharma Trade
  • Performance
  • Orifarm Group A/S - Corporate Strategy
  • Orifarm Group A/S - SWOT Analysis
  • SWOT Analysis - Overview
  • Orifarm Group A/S - Strengths
  • Orifarm Group A/S - Weaknesses
  • Orifarm Group A/S - Opportunities
  • Orifarm Group A/S - Threats
  • Orifarm Group A/S - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Orifarm Group A/S, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Aug 28, 2024: Orifarm Group Appoints New CFO
  • May 05, 2024: Orifarm Data Community talks AI and machine-learning
  • Apr 23, 2024: Orifarm Prepares for Further Growth
  • Apr 09, 2024: Orifarm launches its own Artificial Intelligence tools
  • Apr 05, 2024: Orifarm Announces Relocation from Orifarm Denmark to Orifarm Norway
  • Jan 31, 2024: Orifarm Adjusts Its Operating Model to Become Even More Customer Focused and Agile
  • Jan 09, 2024: Orifarm Announces New Chief Corporate Compliance Officer
  • Oct 30, 2023: Orifarm Appoints New Chief People Officer
  • Oct 09, 2023: Strengthening life science in Funen
  • Sep 29, 2023: Orifarm awarded Best Imported Pharmaceuticals Supplier in Europe in 2023
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Orifarm Group A/S, Key Facts
  • Orifarm Group A/S, Key Employees
  • Orifarm Group A/S, Key Employee Biographies
  • Orifarm Group A/S, Major Products and Services
  • Orifarm Group A/S, History
  • Orifarm Group A/S, Subsidiaries
  • Orifarm Group A/S, Key Competitors
  • Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • Orifarm Group A/S, Recent Deals Summary
List of Figures
  • Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Straumann Danmark ApS
  • ScanimalHealth ApS
  • Paranova Group A/S
  • Acino International AG
  • Falck Hjemmepleje A/S